# Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock

> **NCT02668432** · PHASE4 · TERMINATED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 9 (actual)

## Conditions studied

- New Onset Atrial Fibrillation
- Severe Sepsis
- Septic Shock

## Interventions

- **DRUG:** Amiodarone

## Key facts

- **NCT ID:** NCT02668432
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05
- **Primary completion:** 2018-09-20
- **Final completion:** 2018-09-20
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Investigator left institution
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02668432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02668432, "Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02668432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*